For 1540–1565 nm nonablative fractional erbium lasers, commonly recommended starting parameters are approximately 12–18 J/cm², equivalent to about 30–55 mJ per micro-beam, with 125–250 microscopic treatment zones (MTZs)/cm² delivered over 8–12 passes per session. Treatment is generally performed for 3–6 sessions at 2–4-week intervals, with adjustments for the device, skin type, striae maturity, treatment area, and clinical response. These settings are intended for trained clinicians using a device-specific protocol, not as universal prescriptions.
The practical goal is controlled mid-dermal heating without epidermal ablation: use conservative, individualized energy and density, provide adequate anesthesia and cooling, and allow sufficient recovery between sessions.
Recommended Treatment Parameters
Pulse Energy and Fluence
For 1540–1565 nm systems, the primary reference supports 12–18 J/cm² or approximately 30–55 mJ per micro-beam.
Supplementary protocols report similar ranges, including 35–55 mJ per microbeam with a 10-mm tip or approximately 12–14 mJ per microbeam with a 15-mm tip. These values are not interchangeable across devices because spot size, beam geometry, pulse duration, scanning mode, and manufacturer-specific energy calibration differ.
MTZ Density
A typical density range is 125–250 MTZs/cm² per treatment setting or pass, depending on the system’s display and how it defines density.
Repeated passes can produce a substantially higher cumulative MTZ burden. Some protocols report approximately 1,500–2,500 cumulative MTZs/cm² over multiple passes, but this should be interpreted cautiously and verified against the device manufacturer’s measurement method.
Number of Passes
The primary protocol uses 8–12 passes per session. Other fractional nonablative approaches use fewer passes, such as 2–3 passes, particularly when using a lower-dose, higher-density strategy.
The difference reflects variations in device design and treatment philosophy. Pass count should be selected together with fluence, density, pulse duration, and endpoint rather than treated as an independent target.
Treatment Depth and Tissue Target
The intended target is the upper-to-mid dermis, where controlled thermal injury can stimulate collagen and elastin remodeling.
Depending on the system and pulse energy, reported MTZ depths range from approximately 250–750 micrometers, with some stamping configurations reaching close to 1 mm. Depth should remain appropriate for the tissue thickness and location being treated.
Protocol for Striae Rubra and Striae Alba
Assess the Striae Before Treatment
Both striae rubra and striae alba may be treated, but they can respond differently. Rubra are earlier, erythematous lesions, whereas alba are mature, hypopigmented, and more atrophic.
The treatment plan should account for lesion age, width, atrophy, anatomical site, surrounding skin type, tanning history, and the patient’s risk of post-inflammatory hyperpigmentation.
Use Conservative Initial Settings
Striae distensae resemble atrophic scars histologically, so a conservative starting approach is appropriate. One supplementary recommendation is to use approximately 30% less fluence than standard acne-scar settings, then increase cautiously only if the clinical response and recovery are acceptable.
This is particularly important for darker skin types, recently tanned skin, thin skin, and areas prone to prolonged inflammation or pigment alteration.
Suggested Session Schedule
Common protocols use 2–6 sessions spaced 2–4 weeks apart, while broader nonablative fractional scar protocols use 3–5 sessions at 4–6-week intervals.
A shorter interval may be used when erythema and edema have fully resolved and the treatment intensity is modest. Longer intervals are more appropriate when using higher cumulative energy, treating extensive areas, or waiting for collagen remodeling to become clinically apparent.
Adjust for Skin Type and Device Geometry
Energy should be reduced when the system produces greater thermal accumulation, when the patient has a higher pigmentary risk, or when multiple passes are used.
Spot size also changes the delivered energy density. A setting expressed in millijoules per microbeam cannot be transferred directly between a 10-mm and 15-mm tip, or between different manufacturers’ platforms.
Peri-Procedural Treatment Protocol
Skin Preparation
The treatment area should be thoroughly cleansed and free of cosmetics, oils, topical medications, and other contaminants.
Topical local anesthesia is commonly applied before treatment. The duration of application and removal method should follow the anesthetic product instructions and the clinic’s safety protocol.
Cooling and Thermal Control
Forced-air or contact cooling can improve comfort and reduce excessive epidermal heating.
Cooling is particularly relevant with mid-infrared wavelengths because heat can spread beyond the individual beam path. The epidermis should remain protected while the dermis receives the intended fractional thermal injury.
Treatment Endpoint
The endpoint should be assessed clinically rather than defined solely by a fixed number of passes. Expected findings may include transient erythema, edema, and mild petechiae, but excessive whitening, blistering, persistent pain, or marked confluent thermal injury indicates that treatment intensity or thermal management requires reassessment.
Post-Treatment Care
Patients should apply a bland, hydrating moisturizer repeatedly during the early recovery period.
They should also use strict sun avoidance and broad-spectrum photoprotection because ultraviolet exposure can increase the risk of post-inflammatory hyperpigmentation and interfere with assessment of treatment response.
Expected Recovery and Outcomes
Typical Short-Term Effects
Nonablative fractional treatment preserves the stratum corneum and does not create an open ablative wound.
Transient edema may last approximately 24–72 hours, while mild erythema and petechiae commonly resolve within about 72 hours, although individual recovery varies with treatment intensity and skin type.
Mechanism of Improvement
The laser creates fractional microthermal zones within the dermis. The subsequent wound-healing response can increase dermal thickness and promote collagen and elastic-fiber remodeling while preserving intervening untreated tissue.
Clinical improvement is usually gradual rather than immediate because remodeling continues after the visible short-term inflammation has subsided.
Reported Degree of Improvement
The supplied references report clinical improvement of approximately 26%–75%. This is a broad range and should not be presented as a guaranteed result because outcomes depend on striae maturity, baseline atrophy, skin type, device parameters, treatment number, and assessment method.
Understanding the Trade-offs
Higher Energy Is Not Automatically Better
Increasing fluence or the number of passes may increase dermal heating, but it also increases edema, erythema, pain, prolonged inflammation, and pigmentary risk.
The objective is adequate remodeling with controlled recovery, not the maximum possible thermal injury.
Density and Passes Must Be Considered Together
A high MTZ density combined with many passes can produce substantial cumulative thermal exposure even when the per-pass energy appears modest.
Protocols should therefore record total passes, density per pass, pulse energy, tip size, and treatment endpoint rather than documenting fluence alone.
Published Settings Are Not Fully Transferable
Values reported in J/cm², mJ per microbeam, and total session energy may describe different device architectures or calculation methods.
A clinician should confirm how the specific platform defines fluence, microbeam energy, spot size, density, and cumulative energy before adapting a published protocol.
Pigmentary Risk Requires Individualization
Nonablative treatment generally has less downtime than ablative resurfacing, but it can still provoke post-inflammatory hyperpigmentation, especially in darker or recently exposed skin.
Conservative parameters, adequate cooling, careful patient selection, strict photoprotection, and appropriate intervals are central to risk reduction.
Making the Right Choice for Your Goal
The correct settings should be selected by a qualified clinician after evaluating the patient and confirming the device-specific energy and density definitions.
- If your primary focus is conservative treatment: Begin near the lower end of the device-validated energy range, use controlled density, and extend the interval if inflammation persists.
- If your primary focus is dermal remodeling: Target the upper-to-mid dermis with individualized energy and density while monitoring cumulative exposure across all passes.
- If your primary focus is minimizing hyperpigmentation: Reduce fluence and thermal accumulation, use effective cooling, avoid treating recently tanned skin, and enforce strict post-treatment sun protection.
- If your primary focus is treating mature striae alba: Expect gradual improvement over multiple sessions and avoid assuming that higher energy alone will overcome established atrophy.
- If your primary focus is treating striae rubra: Use a conservative fractional remodeling protocol while accounting for the lesion’s vascular color and the patient’s inflammatory response.
A well-controlled, device-specific protocol with conservative escalation is more reliable than applying a fixed laser setting to every patient.
Summary Table:
| Parameter | Typical Range | Notes |
|---|---|---|
| Fluence | 12–18 J/cm² | Equivalent to 30–55 mJ/micro-beam |
| MTZ Density | 125–250 MTZs/cm² per pass | Cumulative may reach 1500–2500 MTZs/cm² |
| Number of Passes | 8–12 per session | Some protocols use 2–3 passes |
| Number of Sessions | 3–6 sessions | At 2–4 week intervals |
| Treatment Depth | 250–750 μm | Depending on device and settings |
| Target Tissue | Upper-to-mid dermis | Stimulates collagen and elastin remodeling |
Master the art of striae treatment with BELIS's advanced 1540–1565 nm fractional erbium lasers. Our professional-grade devices, designed for clinics and premium salons, offer precision and safety. Contact us today to enhance your practice with our cutting-edge technology and expert support. Get in touch for a customized solution that meets your aesthetic goals.
Related Products
- Fractional CO2 Laser Machine for Skin Treatment
- Professional Face and Vaginal 7D HIFU System for HIFU Clinic Treatments
- 22D HIFU Machine Device Facial Machine
- Vaginal Tighten HIFU Gynecology HIFU Treatment
- Fractional CO2 Laser Machine for Skin Treatment
People Also Ask
- What is the technical principle behind CO2 Laser Fractional micro-perforations? Master Scar Revision Mechanics
- What are the clinical technical advantages of micro-ablative fractional CO2 lasers? Safety vs. Traditional Ablation
- Why do fractional CO2 laser parameters need to be differentiated? Master Keloid vs. Hypertrophic Scar Treatment
- How does the microsecond-level pulse duration setting affect fractional CO2 laser outcomes? Master Thermal Precision
- How should laser power output be adjusted based on tissue vaporization? Mastery of Fractional CO2 Precision